Leveraging technology to combat substandard, falsified medicines in Africa
The proliferation of substandard and falsified (SF) medicines has remained a global scourge, particularly in low-and-middle-income countries (LMICs) like those in Africa, where supply chain security is limited, undermining progress towards meeting the Sustainable Development Goals (SDGs). Inadequate resource allocation to routine quality control (QC) and poor supply chain management, among other factors, increase the […]
read more Leveraging technology to combat substandard, falsified medicines in Africa
